Meloxicam is used for: Rheumatoid arthritis; Osteoarthritis; Ankylosing spondylitis.
Recorded in the NepalDoc medicine catalog for Meloxicam.
Meloxicam tablet USP is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) Rheumatoid Arthritis (RA) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg 1.1 Osteoarthritis (OA Meloxicam tablets USP are indicated for relief of the signs and symptoms of osteoarthritis. 1.2 Rheumatoid Arthritis (RA) Meloxicam tablets USP are indicated for relief of the signs and symptoms of rheumatoid arthritis.
From the U.S. FDA-approved label for Meloxicam. Full label: DailyMed.
Meloxicam tablet USP is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) Rheumatoid Arthritis (RA) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg 1.1 Osteoarthritis (OA Meloxicam tablets USP are indicated for relief of the signs and symptoms of osteoarthritis. 1.2 Rheumatoid Arthritis (RA) Meloxicam tablets USP are indicated for relief of the signs and symptoms of rheumatoid arthritis.
From the U.S. FDA-approved label for Meloxicam. Full label: DailyMed.
Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals OA and RA: Starting dose: 7.5 mg once daily Dose may be increased to 15 mg once daily JRA: 7.5 mg once daily in children ≥60 kg Meloxicam Tablets are not interchangeable with approved formulations of oral meloxicam even if the total milligram strength is the same 2.1 General Dosing Instructions Carefully consider the potential benefits and risks of meloxicam tablets and other treatment options before deciding to use meloxicam tablets.
Directions from the U.S. FDA-approved label for Meloxicam — your doctor or pharmacist may advise differently.
Meloxicam is contraindicated in the following patients: Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs.
Excerpt from the U.S. FDA-approved label for Meloxicam. Talk to a pharmacist or doctor before use.
Hepatotoxicity: Inform patients of warning signs and symptoms of hepatotoxicity. Discontinue if abnormal liver tests persist or worsen or if clinical signs and symptoms of liver disease develop Hypertension: Patients taking some antihypertensive medications may have impaired response to these therapies when taking NSAIDs.
Warnings and precautions excerpt from the U.S. FDA-approved label for Meloxicam — not a complete list. Talk to a pharmacist or doctor before use.
Most common (≥5% and greater than placebo) adverse events in adults are diarrhea, upper respiratory tract infections, dyspepsia, and influenza-like symptoms Adverse events observed in pediatric studies were similar in nature to the adult clinical trial experience To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc. at 1-800-399-2561 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Meloxicam — not a complete list. Talk to a pharmacist or doctor about side effects.
6 brands · 3 makers in the NepalDoc catalog — see the full Meloxicam guide →
Storage Store at 20° to 25°C (68° to 77°F). Keep this and all medications out of the reach of children.
Storage information from the U.S. FDA-approved label for Meloxicam.
What is Muvera?
Muvera 7.5mg Tablet is a Meloxicam medicine made by Sun Pharmaceutical Industries Ltd. It comes as 7.5mg Tablet.
What is Muvera used for?
Meloxicam is used for Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis.
What is the generic name of Muvera?
The generic name of Muvera is Meloxicam.
Which brands of Meloxicam are available in Nepal?
6 brands of Meloxicam are listed in the NepalDoc catalog, from 3 makers — including M-Cam 7.5mg Tablet, M-Cam 15mg Tablet, Muvera 15mg Tablet, Oxichem 15mg Tablet, Oxichem 7.5mg Tablet.
What are the side effects of Meloxicam?
Most common (≥5% and greater than placebo) adverse events in adults are diarrhea, upper respiratory tract infections, dyspepsia, and influenza-like symptoms Adverse events observed in pediatric studies were similar in nature to the adult clinical trial experience To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.